While the holiday season put a (deceptive) dent in the number of registered respiratory infections in Hungary, the ...

While the holiday season put a (deceptive) dent in the number of registered respiratory infections in Hungary, the ...

The NHS is under intense pressure amid a rise in cases of a globally spreading virus - with hospitals across the nation ...

At Tuesday's meeting of the Georgia Board of Public Health, state epidemiologist Cherie Drenzek said flu may have reached its ...

Moderna shares will likely remain under scrutiny after plunging nearly 17% Monday as the embattled drug maker slashed its ...

Moderna pulled in most of its revenue last year from its COVID-19 vaccine, Spikevax, which brought in more than $3 billion in sales. Regulators also approved a Moderna vaccine for RSV, or respiratory ...

Respiratory illnesses, including COVID-19, influenza, and RSV, are surging across the United States, with healthcare systems ...

Getting your influenza vaccinations can limit the complications,” says Dr. Karim Ali, who leads Niagara Health’s infectious ...

Moderna now expects 2025 revenue to come in between $1.5 billion and $2.5 billion, most of which will come in the second half of the year.

Mahmoudi believes there’s one reason emergency visits, and hospitalizations, have declined. “The decrease in hospitalization can be attributed directly to vaccines and the success of them,” ...

There are fears the NHS may be set to face its worst ever winter flu season after cases soared around the country in late ...